Three international organisations, the Global Fund, USAID and Stop TB Partnership, have entered into a collaboration with Molbio Diagnostics to expand access to the Goa-based company’s Truenat platform.
India has only 17 profitable unicorn start-ups, according to market research platform, Tracxn. The country houses 114 unicorns of which 80 startups' data is publicly available. A unicorn is a company valued at $1 billion or above. The data has been extracted from financial statements of FY21 and FY22. Other profitable start-ups in the list are Molbio Diagnostics, Uniphore, Xpressbees, Physicswallah, IPO-bound Mamaearth, CoinDCX, and more.
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the United States Agency for International Development (USAID) and the Stop TB Partnership announced a new collaboration today with Molbio Diagnostics that significantly reduces the price of the Truenat® MTB and MTB Plus tests, including a supply of MTB-RIF Dx tests for subsequent testing for rifampicin resistance, and ensures timely service and maintenance of diagnostic instruments.
Molbio Diagnostics has made a significant contribution to tackling tuberculosis (TB) through its latest announcement of the largest multi-country roll-out of a TB test. The Indian-based company has developed a breakthrough technology called TrueNat, which offers accurate and affordable testing for TB within 60 minutes.
The last startup to reach the $1 billion valuation in India was Goa-based diagnostics chain Molbio Diagnostics, which had raised funds at a valuation of $1.6 billion in September 2022.
Five districts in Kashmir have reported zero Tuberculosis cases, as per a District Level Annual Survey conducted by National Tuberculosis Elimination Program (NTEP) Kashmir for the Sub National Certification.
Truenat MTB-INH is also expected to play a major role internationally, in high TB-burden countries as well as countries that already have a policy in place for INH testing on all TB-positive samples, it claimed.
For the first time a Goan company Molbio Diagnostics, Verna figured among India’s 500 most valuable companies ranking published in the second edition of 2022 Burgundy Private Hurun India 500.
Goa-based Molbio Diagnostics, which came up with a portable, battery operated RT-PCR point of care testing system that revolutionised India’s Covid-19 testing in the hinterland, is now planning to develop a plethora of tests to fuel its future growth
Goa based diagnostic company showcases its unique Truenat® Technology which is all set to come in handy for many countries in the elimination of Tuberculosis (TB). The hallmark of this technology is unprecedented maximum accuracy, duly endorsed by WHO (World Health Organization).
